{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:13:05Z","timestamp":1771636385581,"version":"3.50.1"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bpg.2024.101955","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T06:59:58Z","timestamp":1729753198000},"page":"101955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Gut microbiome in children undergoing hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"72","author":[{"given":"Pawe\u0142","family":"J\u00f3zefczuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Bili\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Minkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"\u0141aguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bpg.2024.101955_bib1","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/cancers12051326","article-title":"Fungal gut microbiota dysbiosis and its role in colorectal, oral, and pancreatic carcinogenesis","volume":"12","author":"Ka\u017amierczak-Siedlecka","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.bpg.2024.101955_bib2","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1080\/19490976.2020.1764309","article-title":"Therapeutic methods of gut microbiota modification in colorectal cancer mangement \u2013 fecal microbiota transplantion, prebiotics, probiotics, and synbiotics","volume":"11","author":"Ka\u017amierczak-Siedlecka","year":"2020","journal-title":"Gut Microb"},{"issue":"5519","key":"10.1016\/j.bpg.2024.101955_bib3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.1058709","article-title":"Comensal host-bacterial relationship in the gut","volume":"292","author":"Hooper","year":"2001","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bpg.2024.101955_bib4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.chom.2023.05.024","article-title":"Enterosignatures define common bacterial guilds in the human gut microbiome","volume":"31","author":"Frioux","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bpg.2024.101955_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000332975","article-title":"Gut microbiota and its pathophysiology in disease paradigms","volume":"29","author":"Festi","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.bpg.2024.101955_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/anae.1997.0102","article-title":"The intestinal microflora during the first weeks of life","volume":"3","author":"Bezirtzoglou","year":"1997","journal-title":"Anaerobe"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_bib7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3748\/wjg.v20.i4.908","article-title":"Inflamation and colorectal cancer, when microbiota-host mutualizm breaks","volume":"20","author":"Candela","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"6012","key":"10.1016\/j.bpg.2024.101955_bib8","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1126\/science.1195568","article-title":"Has the microbiota played a critical role in the evolution of the adaptive immune system?","volume":"330","author":"Lee","year":"2010","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bpg.2024.101955_bib9","first-page":"98","article-title":"Diet, anaerobic bacterial metabolism and colon cancer: a review of the literature","volume":"39","author":"McGarr","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101955_bib10","doi-asserted-by":"crossref","unstructured":"Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006 Dec21; 444(7122):1022-1023.","DOI":"10.1038\/4441022a"},{"issue":"34","key":"10.1016\/j.bpg.2024.101955_bib11","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.bpg.2024.101955_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41390-018-0191-9","article-title":"The contribution of the gut microbiome to neurodevelopment and neuropsychiatric disorders","volume":"85","author":"Warner","year":"2019","journal-title":"Pediatr Res"},{"issue":"9","key":"10.1016\/j.bpg.2024.101955_bib13","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1038\/s41380-023-02287-6","article-title":"Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions","volume":"28","author":"Hashimoto","year":"2023","journal-title":"Mol Psychiatr"},{"issue":"6","key":"10.1016\/j.bpg.2024.101955_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41569-022-00825-3","article-title":"The oral microbiome in pathophysiology o cardiovascular disease","volume":"20","author":"Tonelli","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.bpg.2024.101955_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.903570","article-title":"The gut microbiota (microbiome) in cardiovascular disease and its therapeutic regulation","volume":"12","author":"Rahman","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"10.1016\/j.bpg.2024.101955_bib16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cel transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bpg.2024.101955_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3747\/co.26.5033","article-title":"A general practitioner's guide to hematopoietic stem-cell transplantation","volume":"26","author":"Bazinet","year":"2019","journal-title":"Curr Oncol"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/ciy153","article-title":"Gut microbiome composition predicts infection risk during chemotherapy in children with acute limphoblastic leukemia","volume":"67","author":"Hakim","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bpg.2024.101955_bib19","series-title":"The EBMT handbook","year":"2019"},{"issue":"9674","key":"10.1016\/j.bpg.2024.101955_bib20","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft versus host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2024.101955_bib21","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","article-title":"Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria","volume":"117","author":"Flowers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2024.101955_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2024.101955_bib23","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","article-title":"Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate","volume":"80","author":"Nash","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2024.101955_bib24","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.bbmt.2019.07.006","article-title":"Intestinal microbiota can predict acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Han","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bpg.2024.101955_bib25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/bmt.2015.16","article-title":"Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT","volume":"50","author":"Biagi","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bpg.2024.101955_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/biology11050785","article-title":"Gut microbiome suffers from hematopoietic stem cell transplantation in childhood and its characetristics are positively associated with intra-hospital physical excercise","volume":"11","author":"Ugrayov\u00e1","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.bpg.2024.101955_bib27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbmt.2014.01.030","article-title":"Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease","volume":"20","author":"Holler","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6469","key":"10.1016\/j.bpg.2024.101955_bib28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.aax3760","article-title":"Lactose drives Enterococcus expansion to promote graft-versus-host disease","volume":"366","author":"Stein-Thoeringer","year":"2019","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bpg.2024.101955_bib29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as predictor of mortality in allogenic hematopoietic-cell transplantation","volume":"382","author":"Peled","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bpg.2024.101955_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12920-019-0494-7","article-title":"Early gur microbiota signature of aGvHD in children given allogenic hematopietic cell transplantation for hematological disorders","volume":"12","author":"Biagi","year":"2019","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.bpg.2024.101955_bib31","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.bbmt.2015.04.016","article-title":"Intestinal Blautia is associated with reduced death from graft-versus-host disease","volume":"21","author":"Jenq","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bpg.2024.101955_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-021-01100-2","article-title":"Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation","volume":"9","author":"Ingham","year":"2021","journal-title":"Microbiome"},{"issue":"7","key":"10.1016\/j.bpg.2024.101955_bib33","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bbmt.2017.03.025","article-title":"Gut colonization by multidrug \u2013 resistant Gram \u2013 negative bacteria is an\/independent risk factor for development of intestinal acute graft \u2013 versus \u2013 host disease","volume":"23","author":"Peric","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bpg.2024.101955_bib34","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/cid\/cix699","article-title":"Stool microbiota at neutrophil recovery is predictive for severe acute graft vs host disease after hematopoietic cell transplantation","volume":"65","author":"Golob","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.bpg.2024.101955_bib35","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.2023020026","article-title":"Gut microbiota diversity before allogenic hematopoietic stem cel transplantation as a predictor of mortality in children","volume":"142","author":"Masetti","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bpg.2024.101955_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbmt.2012.09.001","article-title":"Influence of donor microbiota on the severity of experimental graft -versus-host disease?","volume":"19","author":"Tawara","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bpg.2024.101955_bib37","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2010.31.8121","article-title":"Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia","volume":"29","author":"Walter","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2024.101955_bib38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2011.36.9868","article-title":"Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis","volume":"30","author":"Brunet","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2024.101955_bib39","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2024.101955_bib40","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/sj.leu.2403967","volume":"19","author":"Aoudjhane","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bpg.2024.101955_bib41","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2024.101955_bib42","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2010-05-285304","article-title":"Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood","volume":"116","author":"Brunstein","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2024.101955_bib43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(12)70004-9","article-title":"Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study","volume":"13","author":"Fleischhauer","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpg.2024.101955_bib44","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1182\/blood-2007-06-095265","article-title":"The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation","volume":"110","author":"Shaw","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2024.101955_bib45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2024.101955_bib46","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbmt.2010.04.004","volume":"16","author":"Pavletic","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bpg.2024.101955_bib47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_bib48","first-page":"1277","article-title":"Early relapse prediction after allogenic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage \u2013 specific chimerism analysis","volume":"3","author":"Lindahl","year":"2022","journal-title":"EJH"},{"issue":"15","key":"10.1016\/j.bpg.2024.101955_bib49","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.2016.70.3348","article-title":"Intestinal microbiota and relapse after hematopoietic-cell transplantation","volume":"35","author":"Peled","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.bpg.2024.101955_bib50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bpg.2024.101955_bib51","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bpg.2024.101955_bib52","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbmt.2009.02.012","article-title":"Defining conditioning regimens for BMT\u2014recognition of \u201dregimens of intermediate intensity","volume":"15","author":"Russell","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6516","key":"10.1016\/j.bpg.2024.101955_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay9097","article-title":"Multi-omics analyses of radiation survivors identify radioprotective microbs and metabolites","volume":"370","author":"Guo","year":"2020","journal-title":"Science"},{"issue":"37","key":"10.1016\/j.bpg.2024.101955_bib54","doi-asserted-by":"crossref","first-page":"13254","DOI":"10.1073\/pnas.0504830102","article-title":"Microbial regulation of intestinal radiosensitivity","volume":"102","author":"Crawford","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.bpg.2024.101955_bib55","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","article-title":"Personalized mapping o drug metabolism by the human gut microbiome","volume":"181","author":"Javdan","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bpg.2024.101955_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/1078-0432.CCR-22-1254","article-title":"Conditioning regimens are associated with distinct patterns of microbiota injury in allogenic hematopoietic cell transplantation","volume":"29","author":"Shouval","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.bpg.2024.101955_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/biology11050785","article-title":"Gut microbiome suffers from hematopoietic stem cell transplantation in childhood and its characetristics are positively associated with intra-hospital physical excercise","volume":"11","author":"Ugrayov\u00e1","year":"2022","journal-title":"Biology"},{"issue":"5","key":"10.1016\/j.bpg.2024.101955_bib58","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2007-965571","article-title":"Benefits of intrahospital exercise training after pediatric bone marrow transplantation","volume":"29","author":"San Juan","year":"2008","journal-title":"Int J Sports Med"},{"issue":"1","key":"10.1016\/j.bpg.2024.101955_bib59","first-page":"49","article-title":"Impact of decontamination therapy on gastrointestinal acute graft-versus-host-disease after allogenic hematopoietic cel transplantation in children: decontamination therapy in allo-HCT","volume":"12","author":"Ga\u0142\u0105zka","year":"2019","journal-title":"BMC Med Genom"},{"issue":"9","key":"10.1016\/j.bpg.2024.101955_bib60","article-title":"Complete suppression o the gut microbiome prevents acute graft \u2013 versus \u2013 host disease following allogenic bone marrow transplantation","volume":"9","author":"Voosen","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bpg.2024.101955_bib61","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bbmt.2017.02.004","article-title":"Antibiotic induced depletion of anti-inflammatory Clostridia is associated with the development of graft-versus-host disease in pediatric stem cel transplantation patients","volume":"23","author":"Sunkersett","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bpg.2024.101955_bib62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.trsl.2016.07.013","article-title":"Toward revision of antimicrobial therapies in hematopoietic stem cell transpalntation: target the pathogens, but protect the indigenous microbiota","volume":"179","author":"Khoruts","year":"2017","journal-title":"Transl Res"},{"issue":"7","key":"10.1016\/j.bpg.2024.101955_bib63","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogenic hematopoietic stem cell transplantation","volume":"55","author":"Taur","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.bpg.2024.101955_bib64","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1172\/JCI43918","article-title":"Vancomycin \u2013 resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans","volume":"120","author":"Ubeda","year":"2010","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.bpg.2024.101955_bib65","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","article-title":"The effects of intestinal tract bacterial diversity on mortality following allogenic hematopoietic stem cel transplantation","volume":"124","author":"Taur","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_bib66","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/bjh.16218","article-title":"Pilot study investigating the effect of enteral and parenteral nutrition on the gastrointestinal microbiome post-allogenic transplantation","volume":"188","author":"Andersen","year":"2020","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.bpg.2024.101955_bib67","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.3390\/nu11122958","article-title":"Enteral nutrition in pediatric patients undergoing hematopoietic SCT promotes the recovery of gut microbiome homeostasis","volume":"11","author":"D'Amico","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.bpg.2024.101955_bib68","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41564-024-01617-w","article-title":"Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft versus host disease","volume":"9","author":"Linder","year":"2024","journal-title":"Nat Microbiol"},{"issue":"2","key":"10.1016\/j.bpg.2024.101955_bib69","doi-asserted-by":"crossref","first-page":"180.e1","DOI":"10.1016\/j.jtct.2020.11.006","article-title":"Enteral versus parenteral nutrition as nutritional support after allogenic hematopoietic stem cel transplantation:a systematic review and meta-analysis","volume":"27","author":"Zama","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.bpg.2024.101955_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12937-020-00537-9","article-title":"Enteral nutrition protects children undergoing allogeneic hematopoietic stem cel transplantation from blood stream infections","volume":"19","author":"Zama","year":"2020","journal-title":"Nutr J"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_bib71","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/bmjspcare-2018-001742","article-title":"Neutropenic diets to prevent cancer infections: updated systematic review and meta-analysis","volume":"9","author":"Sonbol","year":"2019","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.bpg.2024.101955_bib72","series-title":"C\u00f3rdoba, Argentina: food and agriculture organization of the united nations and","article-title":"Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria","year":"2001"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_bib73","first-page":"CD004827","article-title":"Probiotics for the prevention of pediatric antibiotic-associated diarrhea","volume":"2019","author":"Guo","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpg.2024.101955_bib74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11899-016-0302-9","article-title":"Microbiota manipulation with prebiotics and probiotics in patients undergoing stem cell transplantation","volume":"11","author":"Andermann","year":"2016","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.bpg.2024.101955_bib75","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12602-018-9399-6","article-title":"Septicemia from lactobacillus rhamnosus GG, from a probiotic enriched yogurt, in a patient with autologous stem cell transplantation","volume":"11","author":"Koyama","year":"2019","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"10.1016\/j.bpg.2024.101955_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037971","article-title":"Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model","volume":"7","author":"Bindels","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bpg.2024.101955_bib77","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1182\/blood.V124.21.5877.5877","article-title":"Probiotic enteric regimen for easing the complications of transplant","volume":"124","author":"Gorshein","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bpg.2024.101955_bib78","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40121-019-0244-3","article-title":"Safety of probiotics among high-risk pediatric hematopoietic stem cell transplant recipients","volume":"8","author":"Sadanand","year":"2019","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.bpg.2024.101955_bib79","first-page":"262","volume":"51","author":"Ladas","year":"2016","journal-title":"The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplant"},{"key":"10.1016\/j.bpg.2024.101955_bib80","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bpg.2024.101955_bib81","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09646","article-title":"Bifidobacteria can protect from enteropathogenic infection through production of acetate","volume":"469","author":"Fukuda","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2024.101955_bib82","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00284-020-02053-9","article-title":"Saccharomyces boulardii (CNCM I-745): a non-bacterial microorganism used as probiotic agent in supporting treatment of selected diseases","volume":"77","author":"Ka\u017amierczak-Siedlecka","year":"2020","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.bpg.2024.101955_bib83","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s005200000123","article-title":"Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii","volume":"8","author":"Cesaro","year":"2000","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bpg.2024.101955_bib84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/00365540510026454","article-title":"Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole","volume":"37","author":"Burkhardt","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.bpg.2024.101955_bib85","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s12602-017-9332-4","article-title":"Experience with Saccharomyces boulardii probiotic in oncohaematological patients","volume":"10","author":"Sulik-Tyszka","year":"2018","journal-title":"Probiotics Antimicrob. Proteins."},{"issue":"8","key":"10.1016\/j.bpg.2024.101955_bib86","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.bbmt.2012.02.010","article-title":"Clostridium difficile infection after allogenic hematopoietic stem cel transplantation: incidence, risk factors and outcome","volume":"18","author":"Willems","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_bib87","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/QCO.0b013e3283630c4c","article-title":"Clostridium difficile infection among hematopoietic stem cel transplant recipients: beyond colitis","volume":"26","author":"Alonso","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.bpg.2024.101955_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090158","article-title":"Early Clostridium difficile infection during allogenic hematopoietic stem cell stransplantation","volume":"9","author":"Kinnebrew","year":"2014","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.bpg.2024.101955_bib89","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of oral capsule -vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridum difficile infection: a randomized clinical trial","volume":"318","author":"Kao","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_bib90","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajg.2013.59","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis","volume":"108","author":"Kassam","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_bib91","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jiac.2015.01.011","article-title":"Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients","volume":"21","author":"Di Bella","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.bpg.2024.101955_bib92","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1097\/MCG.0b013e318222e603","article-title":"Fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"45","author":"Brandt","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2024.101955_bib93","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.02366","article-title":"Randomized double-blind phase II trial of fecal microbiota transplantation versus placebo in allogeneic hematopoietic cell transplantation and AML","author":"Rashidi","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2024.101955_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13052-019-0708-9","article-title":"Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report","volume":"45","author":"Zhong","year":"2019","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.bpg.2024.101955_bib95","doi-asserted-by":"crossref","first-page":"69","DOI":"10.18620\/ctt-1866-8836-2021-10-1-69-78","article-title":"Clinical and immune effects of fecal microbiota transplantation in children with acute graft-versus-host disease","volume":"10","author":"Goloshchapov","year":"2021","journal-title":"Cell Ther Transplant"},{"issue":"8","key":"10.1016\/j.bpg.2024.101955_bib96","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.cmi.2019.04.006","article-title":"Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review","volume":"25","author":"Saha","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.bpg.2024.101955_bib97","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhin.2019.03.010","article-title":"Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systemiatic review and meta-analysis","volume":"102","author":"Tavoukjian","year":"2019","journal-title":"J Hosp Infect"},{"issue":"3","key":"10.1016\/j.bpg.2024.101955_bib98","first-page":"364","volume":"65","author":"Bilinski","year":"2017","journal-title":"Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: reuslts of a prospective, singel-center study. Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.bpg.2024.101955_bib99","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/cid\/ciaa948","article-title":"Disease prevention not decolonization: a model for fecal microbiota transplantation in patients colonized with multidrug-resistant organisms","volume":"72","author":"Ghani","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.bpg.2024.101955_bib100","article-title":"Fecal microbiota transplant mitigates adverse outcomes seen in patients colonized with multidrug-resistant organisms undergoing allogeneic hematopoietic cell transplantation","volume":"27","author":"Innes","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"16","key":"10.1016\/j.bpg.2024.101955_bib101","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2016-05-717652","article-title":"Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut","volume":"128","author":"Kakihana","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bpg.2024.101955_bib102","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3389\/fimmu.2018.02195","article-title":"Treating steroid refractory intestinal acute graft vs.-host disease with fecal microbiota transplantation: a pilot study","volume":"20","author":"Qi","year":"2018","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.bpg.2024.101955_bib103","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1158\/1078-0432.CCR-23-2369","article-title":"Potential of fecal microbiota transplantation to prevent acute GVHD: analysis from a phase II trial","volume":"29","author":"Rashidi","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"62","key":"10.1016\/j.bpg.2024.101955_bib104","article-title":"Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial","volume":"26","author":"Malard","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"12","key":"10.1016\/j.bpg.2024.101955_bib105","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3390\/antibiotics12121667","article-title":"High diversity but monodominance of multidrug- resistant bacteria in immunocompromised pediatric patients with acute lymphoblastic leukemia developing developing GVHD are not associated with changes in mycrobiome","volume":"12","author":"Sadzikova","year":"2023","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_bib106","doi-asserted-by":"crossref","first-page":"335","DOI":"10.21101\/cejph.a5393","article-title":"Microbiome and diversity indices during blood stem cell transplantation \u2013 new perspectives?","volume":"27","author":"Parco","year":"2019","journal-title":"Cent Eur J Publ Health"},{"issue":"5","key":"10.1016\/j.bpg.2024.101955_bib107","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrc.2018.10","article-title":"Gut microbiota injury in allogenic haematopoietic stem cel transplantation","volume":"18","author":"Shono","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.bpg.2024.101955_fur1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/biomedicines10040837","article-title":"The role o fecal microbiota transplantation in the treatment of acute graft versus host disease","volume":"10","author":"Bili\u0144ski","year":"2022","journal-title":"Biomedicines"},{"issue":"18","key":"10.1016\/j.bpg.2024.101955_fur2","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.3390\/cancers13184665","article-title":"Gut microbiome modulation and faecal microbiota transplantation following allogenic hematopoietic stem cel transplantation","volume":"13","author":"Ka\u017amierczak-Siedlecka","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bpg.2024.101955_fur3","first-page":"67","article-title":"Role of the microbiota in hematologic malignacies","volume":"77","author":"Allegra","year":"2019","journal-title":"Neth J Med"},{"issue":"5","key":"10.1016\/j.bpg.2024.101955_fur4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/nu14050949","article-title":"The intestinal barrier dysfunction as driving factor of inflammaging","volume":"14","author":"Untersmayr","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.bpg.2024.101955_fur5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10620-018-5369-9","article-title":"Microbiome: an emerging new frontier in graft-versus-host disease","volume":"64","author":"Kumari","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"386","key":"10.1016\/j.bpg.2024.101955_fur6","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1126\/scitranslmed.aag2513","article-title":"RIG-I\/MAVS and STING signaling promote gut integrity during irradiation- and immne-mediated tissue injury","volume":"9","author":"Fischer","year":"2017","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.bpg.2024.101955_fur7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bbmt.2017.04.018","article-title":"Hematopoietic stem cell transplantation activity in pediatric cancer between 2008 and 2014 in the United States: a center for international blood and marrow transplant research report","volume":"23","author":"Khandelwai","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bpg.2024.101955_fur8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11899-016-0302-9","article-title":"Microbiota manipulation with prebiotics and probiotics in patients undergoing stem cell transplantation","volume":"11","author":"Andermann","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.bpg.2024.101955_fur9","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/bloodadvances.2020001531","article-title":"Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity","volume":"4","author":"Payen","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.bpg.2024.101955_fur10","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.bbmt.2019.06.001","article-title":"Alteration of the intestinal microbiota by broad-spectrum antibiotic use correlates with the occurrence of intestinal graft-versus-host disease","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bpg.2024.101955_fur11","article-title":"Rationally \u2013 defined microbial consortia suppress multidrug-resistant proinflammatory Enterobacteriaceae via ecological control","volume":"23","author":"Honda","year":"2023","journal-title":"Res Sq"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691824000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691824000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T19:53:45Z","timestamp":1750190025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691824000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":118,"alternative-id":["S1521691824000805"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2024.101955","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome in children undergoing hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2024.101955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101955"}}